In the United States, Pfizer’s revenue was further hit by the loss of exclusivity of high chlorestorol medication, Lipitor (atorvastatin calcium), when its patent ran out in November 2011.

The purchase puts Pfizer in a position to have three blockbuster cholesterol medicines on the market: Lipitor, Esperion's ETC-216 and Pfizer's own experimental cholesterol drug, which company ...

According to West Virginia Attorney General Patrick Morrisey, a $17 million settlement between the state, Pfizer, and Ranbaxy has been approved. The antitrust lawsuit involved a generic, cheaper ...

Pfizer’s monopoly over the blockbuster cholesterol-reducing molecule atorvastatin, trade name Lipitor, ends today (November 30) with the expiration of the patent that has brought the company over $100 ...

Pfizer?s Lipitor brand has partnered with Meredith Corp.?s EatingWell magazine on a mobile application that helps users manage their cholesterol with recipes and heart-healthy tips. The app is ...

John Shipman joins the News Hub to discuss a raft of corporate earnings that will sway markets on Tuesday. Also, Europe's efforts to tie up a new bailout fund lifted overseas markets. AP Photo ...